Last reviewed · How we verify

Hypertensive disorder — Treatment Landscape & Competitive Intelligence

Hypertensive disorder (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypertensive disorder, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Edarbi AZILSARTAN MEDOXOMIL Arbor Pharms Ireland Angiotensin 2 Receptor Blocker AT1 receptor 2011-01-01
Cleviprex CLEVIDIPINE Chiesi Dihydropyridine Calcium Channel Blocker [EPC] Voltage-dependent L-type calcium channel subunit alpha-1C 2008-01-01
Tekturna ALISKIREN Lxo Ireland Renin Inhibitor Renin 2007-01-01
Inspra EPLERENONE Upjohn Aldosterone Antagonist [EPC] Mineralocorticoid receptor 2002-01-01
Benicar OLMESARTAN MEDOXOMIL Cosette Thiazide Diuretic [EPC] Type-1 angiotensin II receptor 2002-01-01
Atacand CANDESARTAN CILEXETIL ANI Pharmaceuticals Angiotensin 2 Receptor Blocker Type-1 angiotensin II receptor 1998-01-01
Micardis TELMISARTAN Boehringer Ingelheim Angiotensin 2 Receptor Blocker [EPC] Type-2 angiotensin II receptor 1998-01-01
Avapro IRBESARTAN Sanofi Angiotensin 2 Receptor Blocker [EPC] Type-1 angiotensin II receptor 1997-01-01
Teveten EPROSARTAN AbbVie Angiotensin 2 Receptor Blocker Type-1 angiotensin II receptor 1997-01-01
Avapro IRBESARTAN HYDROCHLORIDE Sanofi Angiotensin 2 Receptor Blocker [EPC] Type-1 angiotensin II receptor 1997-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 40 drugs in Hypertensive disorder
  2. Pfizer · 8 drugs in Hypertensive disorder
  3. Merck & Co. · 5 drugs in Hypertensive disorder
  4. Boehringer Ingelheim · 3 drugs in Hypertensive disorder
  5. Sanofi · 2 drugs in Hypertensive disorder
  6. Novartis · 2 drugs in Hypertensive disorder
  7. Azurity · 2 drugs in Hypertensive disorder
  8. Lxo Ireland · 2 drugs in Hypertensive disorder
  9. Promius Pharma · 2 drugs in Hypertensive disorder
  10. Arbor Pharms Ireland · 1 drug in Hypertensive disorder
  11. Allergan · 1 drug in Hypertensive disorder
  12. ANI Pharmaceuticals · 1 drug in Hypertensive disorder

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypertensive disorder:

Cite this brief

Drug Landscape (2026). Hypertensive disorder — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypertensive-disorder. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing